Arrowhead Pharmaceuticals Inc (NASDAQ:ARWR)

13.26
Delayed Data
As of 4:00pm ET
 +0.08 / +0.61%
Today’s Change
1.48
Today|||52-Week Range
14.24
+260.33%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$825.0M

Company Description

Arrowhead Pharmaceuticals, Inc. engages as a biopharmaceutical company developing targeted RNAi therapeutics. Its pipeline includes clinical programs in chronic hepatitis B virus and partner based programs in obesity and oncology. The company was founded by R. Bruce Stewart in 1989 and is headquartered in Pasadena, CA.

Contact Information

Arrowhead Pharmaceuticals, Inc.
225 South Lake Avenue
Pasadena California 91101-3009
P:(626) 304-3400
Investor Relations:

Employees

Shareholders

Individual stakeholders4.91%
Other institutional27.59%
Mutual fund holders18.31%

Top Executives

Christopher Richard AnzalonePresident, Chief Executive Officer & Director
Bruce D. GivenChief Operating Officer
Kenneth Allen MyszkowskiCFO & Principal Accounting Officer
Jane DavidsonSecretary, Head-Human Resources & Administration
Peter B. LeoneVice President-Strategic Business Initiatives